(Q30712004)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12127599%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

title

The increased activity of plasma manganese superoxide dismutase in tardive dyskinesia is unrelated to the Ala-9Val polymorphism (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12127599%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12127599%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

author name string

ZhiJun Zhang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12127599%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

XiaoBin Zhang

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12127599%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Gang Hou

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12127599%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

WeiWei Sha

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12127599%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

publication date

1 September 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12127599%20AND%20SRC:MED&resulttype=core&format=json

Journal of Psychiatric Research

11 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12127599%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

volume

36

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12127599%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12127599%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

page(s)

317-324

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12127599%20AND%20SRC:MED&resulttype=core&format=json

Human mitochondrial manganese superoxide dismutase polymorphic variant Ile58Thr reduces activity by destabilizing the tetrameric interface

11 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900007-9

Vitamin E, lipids, and lipid peroxidation products in tardive dyskinesia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900007-9

Aggregation and Motor Neuron Toxicity of an ALS-Linked SOD1 Mutant Independent from Wild-Type SOD1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900007-9

Free radical mechanisms in schizophrenia and tardive dyskinesia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900007-9

Elevated lipid peroxidation and disturbed antioxidant enzyme activities in plasma and erythrocytes of patients with uterine cervicitis and myoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900007-9

Prevalence of tardive dyskinesia, tardive dystonia, and respiratory dyskinesia among Chinese psychiatric patients in Hong Kong

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900007-9

Antioxidant properties of clozapine and related neuroleptics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900007-9

Tardive dyskinesia: possible involvement of free radicals and treatment with vitamin E.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900007-9

Analysis of mitochondrial targeting sequence and coding region polymorphisms of the manganese superoxide dismutase gene in German Parkinson disease patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900007-9

Manganese superoxide dismutase gene polymorphism and schizophrenia: relation to tardive dyskinesia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900007-9

Characterization of the potential antioxidant and pro-oxidant actions of some neuroleptic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900007-9

Oxidative damage in neurodegenerative disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900007-9

Genetic association of manganese superoxide dismutase with exudative age-related macular degeneration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900007-9

Neurodegeneration, myocardial injury, and perinatal death in mitochondrial superoxide dismutase-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900007-9

Increased indices of free radical activity in the cerebrospinal fluid of patients with tardive dyskinesia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900007-9

Oxygen radicals and neuropsychiatric illness. Some speculations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900007-9

Increased manganese-superoxide dismutase activity in postmortem brain from neuroleptic-treated psychotic patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900007-9

Free radical pathology and antioxidant defense in schizophrenia: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900007-9

A novel neurological phenotype in mice lacking mitochondrial manganese superoxide dismutase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900007-9

Association between manganese superoxide dismutase (MnSOD) gene polymorphism and breast cancer risk.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900007-9

At issue: genes, experience, and chance in schizophrenia--positioning for the 21st century

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900007-9

Impaired antioxidant defense at the onset of psychosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900007-9

Mitochondrial susceptibility to oxidative stress exacerbates cerebral infarction that follows permanent focal cerebral ischemia in mutant mice with manganese superoxide dismutase deficiency.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900007-9

Reevaluation of assay methods and establishment of kit for superoxide dismutase activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900007-9

Tardive dyskinesia in non-western countries: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900007-9

Tardive dyskinesia, lipid peroxidation, and sustained amelioration with vitamin E treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900007-9

Loss of ROS--a radical response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900007-9

Enzymes of the antioxidant defense system in chronic schizophrenic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900007-9

Free radical pathology in schizophrenia: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900007-9

On signal sequence polymorphisms and diseases of distribution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900007-9

The current status of tardive dyskinesia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900007-9

Research Diagnoses for Tardive Dyskinesia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900007-9

Association between the serotonin 2C receptor gene and tardive dyskinesia in chronic schizophrenia: additive contribution of 5-HT2Cser and DRD3gly alleles to susceptibility.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900007-9

Structural dimorphism in the mitochondrial targeting sequence in the human manganese superoxide dismutase gene. A predictive evidence for conformational change to influence mitochondrial transport and a study of allelic association in Parkinson's di

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900007-9

Mn SOD activity and protein in a patient with chromosome 6-linked autosomal recessive parkinsonism in comparison with Parkinson's disease and control.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900007-9

Dopamine D3-receptor gene variant and susceptibility to tardive dyskinesia in schizophrenic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900007-9

Markers of glutamatergic neurotransmission and oxidative stress associated with tardive dyskinesia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900007-9

Manganese-containing superoxide dismutase signal sequence polymorphism associated with sporadic motor neuron disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900007-9

Ethnic variation in the mitochondrial targeting sequence polymorphism of MnSOD.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900007-9

Increased oxidative damage is correlated to altered mitochondrial function in heterozygous manganese superoxide dismutase knockout mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900007-9

Low superoxide dismutase activity in schizophrenic patients with tardive dyskinesia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900007-9

Effects of haloperidol on antioxidant defense system enzymes in schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900007-9

Association of a polymorphism in the promoter region of the serotonin 5-HT2C receptor gene with tardive dyskinesia in patients with schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900007-9

10.1016/S0022-3956(02)00007-9

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12127599%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference